DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma-assay validation and clinical experience

Diagnostic Molecular Pathology

Volumn 20, Issue 4, 2011, Pages 218-224

  Narendra, Sonia ^a   Valente, Alfredo ^a   Tull, Jamie ^a   Zhang, Shengle ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

DDIT3 gene; fluorescence in situ hybridization; Myxoid liposarcoma

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; RNA BINDING PROTEIN;

ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE LOCUS; HUMAN; HUMAN TISSUE; METAPHASE; MYXOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

GENE FUSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA, MYXOID; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTOR CHOP; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 81855228654     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3182107eb9     Document Type: Article

References (16)

1. Anonescu C, Ladanyi M. Myxoid Liposarcoma. In: Fletcher CDM, ed. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002:40-43.
2. Weiss SW, Goldblum JR. Myxoid/Round Cell Liposarcoma. In: Weiss SW. 4th eds. Soft Tissue Tumors. St Louis: Mosby Inc; 2001:670-687.
3. Grosso F, Jones RL, Demetri GD, et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 2007;8:565-567.
4. Forni C, Minuzzo M, Virdis E, et al. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. Mol Cancer Ther. 2009;8:449-457.
5. Knight JC, Renwick PJ, Cin PD, et al. Translocation t(12;16) (q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Research. 1995;55:24-27.
6. Panagopoulos I, Hoglund M, Mertens F, et al. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene. 1996;12: 489-494. (Pubitemid 26059642)
7. Hosaka T, Nakashima Y, Kusuzaki K, et al. A novel type of EWS-CHOP fusion gene in two cases of myxoid liposarcoma. J Mol Diagn. 2002;4:164-171.
8. Willeke F, Ridder R, Mechtersheimer G, et al. Analysis ofFUS-CHOP fusion transcripts in different types of soft tissue liposarcoma andtheirdiagnostic implication. Clin CancerRes. 1998;4:1779-1784. (Pubitemid 28304742)
9. Hisaoka M, Tsuji S, Morimitsu Y, et al. Detection of TLS/ FUS-CHOP fusion transcripts in myxoid and round cell liposarco-ma by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissue. Diagn Mol Pathol. 1998;7: 96-101. (Pubitemid 28443097)
10. Powers MP, Wang W-L, Hernandez VS, et al. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants includ-ing a newly identified breakpoint using an optimized RT-PCR assay. Mod Pathol. 2010;23:1307-1315.
11. Panagopoulos I, Mertens F, Isaksson M, et al. A novel FUS/CHOP chimera in myxoid liposarcoma. Biochem Biophys Res Commun. 2000;279:838-845. (Pubitemid 32042864)
12. Downs-Kelly E, Goldblum JR, Patel RM, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol. 2008;32:8-13.
13. Willmore-Payne C, Holden J, Turner KC, et al. Translocation and amplification of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe. Arch Pathol Lab Med. 2008;132:952-957. (Pubitemid 351918701)
14. Bianchini IA, Bonnafous KF, Cardot-Leccia N, et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcoma whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008;122:2233-2241. (Pubitemid 351542325)
15. Sozzi G, Minoletti F, Miozzo M, et al. Relevance ofcytogenetic and fluorescent in situ hybridization analysis in the clinical assessment of soft tissue sarcoma. Human Pathol. 1997;28:134-142. (Pubitemid 27069176)
16. Mezzelani A, Sozzi G, Pierotti MA, et al. Rapid differential diagnosis of myxoid liposarcoma by fluorescence in situ hybridiza-tion on cytological preparations. J Clin Pathol: Mol Pathol. 1996;49:M308-M309.